Horn Howard
Insider CIK 1786335 · RARE Chief Financial Officer · VIR CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-10-15 | 2026-10-19 | 7,066 | $15.27 | $107.9K | 89,229 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-08-03 | 2026-08-04 | 4,696 | $24.92 | $117.0K | 96,295 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-08-03 | 2026-08-04 | 4,696 | $24.92 | $117.0K | 96,295 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-07-01 | 2026-07-06 | 4,698 | $33.13 | $155.6K | 100,991 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-06-01 | 2026-06-01 | 4,653 | $23.77 | $110.6K | 105,689 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-05-01 | 2026-05-04 | 4,683 | $24.90 | $116.6K | 110,342 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-04-16 | 2026-04-20 | 59,952 | — | $0 | 59,952 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-04-16 | 2026-04-20 | 34,674 | — | $0 | 115,025 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-04-01 | 2026-04-02 | 4,683 | $20.97 | $98.2K | 80,351 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-03 | 2026-03-03 | 1,635 | $22.40 | $36.6K | 85,034 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 3,119 | $22.54 | $70.3K | 86,669 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 5,290 | $22.80 | $120.6K | 89,788 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-03-01 | 2026-03-03 | 6,143 | — | $0 | 95,078 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-02-02 | 2026-02-03 | 3,061 | $23.56 | $72.1K | 88,935 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-01-02 | 2026-01-05 | 3,150 | $22.84 | $71.9K | 91,996 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-12-10 | 2025-12-11 | 3,081 | $36.38 | $112.1K | 95,146 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-10-13 | 2025-10-14 | 7,942 | $31.51 | $250.3K | 98,227 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-06 | 2025-03-10 | 1,785 | $40.40 | $72.1K | 106,169 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-03-01 | 2025-03-04 | 28,160 | — | $0 | 28,160 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 15,653 | — | $0 | 107,954 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-10-10 | 2024-10-11 | 7,465 | $52.76 | $393.9K | 92,301 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 34,200 | — | $0 | 34,200 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 19,400 | — | $0 | 99,766 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-10-09 | 2023-10-10 | 140,469 | — | $0 | 140,469 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-10-09 | 2023-10-10 | 80,366 | — | $0 | 80,336 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-23 | 2023-02-24 | 2,248 | $25.97 | $58.4K | 230,712 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 2,424 | $25.29 | $61.3K | 232,960 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-02-22 | 2022-02-24 | 35,000 | — | $0 | 235,384 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-02-17 | 2022-02-22 | 2,393 | $31.93 | $76.4K | 200,384 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-02-16 | 2021-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-02-16 | 2021-02-18 | 25,000 | — | $0 | 202,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-07-13 | 2020-07-15 | 30,000 | $50.06 | $1.50M | 177,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-07-02 | 2020-07-02 | 10,000 | $40.00 | $400.0K | 207,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-07-01 | 2020-07-02 | 9,100 | $37.72 | $343.3K | 218,677 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-07-01 | 2020-07-02 | 500 | $38.78 | $19.4K | 218,177 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-07-01 | 2020-07-02 | 400 | $39.33 | $15.7K | 217,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-06-25 | 2020-06-26 | 30,000 | $50.00 | $1.50M | 227,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-06-19 | 2020-06-23 | 10,000 | $40.00 | $400.0K | 257,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-06-01 | 2020-06-02 | 6,714 | $35.38 | $237.5K | 267,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2020-06-01 | 2020-06-02 | 3,286 | $34.53 | $113.5K | 274,491 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2019-10-10 | 2019-10-11 | 111,111 | — | $0 | 111,111 | SEC↗ |